Greg N Bowden
Overview
Explore the profile of Greg N Bowden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hallak H, Mantziaris G, Pikis S, Islim A, Peker S, Samanci Y, et al.
Acta Neurochir (Wien)
. 2025 Feb;
167(1):37.
PMID: 39912992
Introduction: Management for elderly patients (> 65yo) with incidental meningiomas remains unclear. This study aims to characterize the functional and tumor outcomes of expectant and stereotactic radiosurgery (SRS) management of...
2.
Langlois A, Iorio-Morin C, Kallos J, Niranjan A, Lunsford L, Peker S, et al.
Neurosurgery
. 2025 Jan;
96(4):870-880.
PMID: 39808548
Background And Objectives: Oligodendrogliomas are primary brain tumors classified as isocitrate deshydrogenase-mutant and 1p19q codeleted in the 2021 World Health Organization Classification of central nervous system tumors. Surgical resection, radiotherapy,...
3.
Dayawansa S, Dumot C, Mantziaris G, Xu Z, Pikis S, Peker S, et al.
Sci Rep
. 2024 Oct;
14(1):25933.
PMID: 39472707
Brainstem cerebral cavernous malformations (CCM) are clinically more aggressive compared to superficial CCMs. Due to their location, resection can be challenging, making stereotactic radiosurgery (SRS) an attractive alternative for symptomatic...
4.
Dumot C, Mantziaris G, Dayawansa S, Brantley C, Lee C, Yang H, et al.
Neuro Oncol
. 2024 Jul;
26(12):2328-2338.
PMID: 39028740
Background: A higher risk of secondary brain tumor, carotid stenosis, and stroke has been reported after conventional sella irradiation for pituitary neuroendocrine tumors (PitNET). Stereotactic radiosurgery (SRS), which is a...
5.
Singh R, Dumot C, Mantziaris G, Dayawansa S, Xu Z, Pikis S, et al.
J Neurosurg
. 2023 Dec;
140(6):1762-1768.
PMID: 38064704
Objective: There are few reports of outcomes following stereotactic radiosurgery (SRS) for the management of cerebral cavernous malformations (CCMs) of the basal ganglia or thalamus. Therefore, the authors aimed to...
6.
Dumot C, Mantziaris G, Dayawansa S, Xu Z, Pikis S, Peker S, et al.
Stroke Vasc Neurol
. 2023 Aug;
9(3):221-229.
PMID: 37586775
Background: Cerebral cavernous malformations (CCMs) frequently manifest with haemorrhages. Stereotactic radiosurgery (SRS) has been employed for CCM not suitable for resection. Its effect on reducing haemorrhage risk is still controversial....
7.
Bin-Alamer O, Abou-Al-Shaar H, Mallela A, Kallos J, Deng H, Nabeel A, et al.
Neurosurgery
. 2023 Aug;
94(2):289-296.
PMID: 37581440
Background And Objectives: Intratumoral hemorrhage (ITH) in vestibular schwannoma (VS) after stereotactic radiosurgery (SRS) is exceedingly rare. The aim of this study was to define its incidence and describe its...
8.
Dumot C, Mantziaris G, Pikis S, Dayawansa S, Xu Z, Samanci Y, et al.
J Neurol
. 2023 Jul;
270(10):5048-5056.
PMID: 37405688
Objective: Stereotactic radiosurgery (SRS) has been proposed as an alternative to resection for epilepsy control in patients with cerebral cavernous malformations (CCM) located in critical areas. Methods: This multicentric, retrospective...
9.
Dumot C, Pikis S, Mantziaris G, Xu Z, Dayawansa S, Anand R, et al.
Acta Neurochir (Wien)
. 2022 Dec;
165(1):211-220.
PMID: 36543963
Background: Surgery is the preferred treatment for large vestibular schwannomas (VS). Good tumor control and cranial nerve outcomes were described in selected Koos IV VS after single-session stereotactic radiosurgery (SRS),...
10.
Pikis S, Mantziaris G, Anand R, Nabeel A, Sheehan D, Sheehan K, et al.
J Neurosurg
. 2022 Oct;
138(2):405-412.
PMID: 36303474
Objective: Though stereotactic radiosurgery (SRS) is an established safe treatment for small- and medium-sized vestibular schwannomas (VSs), its role in the management of Koos grade IV VS is still unclear....